If you made any changes in Pure these will be visible here soon.

Personal profile


Senior Lecturer - Centre for Medicine Use and Safety

NHMRC Career Development Fellowship (CDF)- Drug Delivery, Disposition and Dynamics Faculty of Pharmacy and Pharmaceutical Sciences


Related Links: 

Research interests

Antibiotic mono- and combination therapy to achieve synergistic bacterial killing and prevent resistance Population pharmacokinetics, pharmacodynamics, and optimised dosage regimens of anti-infectives and other agents

Tissue penetration into bone and other tissues

Drug-drug interactions and their analysis by mechanism-based mathematical models

Mechanism-based population modelling of the glucose-insulin system, drug effects and disease progression in type 2 diabetes

Renal elimination mechanisms

Monash teaching commitment

Coordinating the CMUS PhD student training (CMUS masterclasses)

PSC2041 / BPS2041 Biopharmaceutics (second year Pharm Sci) - Unit coordinator and teaching pharmacokinetics

PAC3191 Microbiology and Immunology (third year Pharmacy) - Unit coordinator

PHR1022 How Medicines Work II (first year Pharmacy) - teaching pharmacokinetics, pharmacogenomics, pharmacokinetics/pharmacodynamics

PSC3212 Product Commercialistion (third year Pharm Sci) - teaching in vitro / in vivo correlation, bioavailability, bioequivalence, target effects

PhD student training in workshops on mechanism-based, population pharmacokinetic / pharmacodynamic modelling and simulation

Teaching applications of mechanism-based modelling to pharmaceutical industry

Education/Academic qualification

Pharmaceutical Sciences, PhD, University of Wuerzburg


Pharmacy and Pharmaceutical Sciences, BPharm, Universitat Regensburg (University of Regensburg)


External positions

Adjunct Assistant Professor, University at Buffalo, The State University of New York

15 Aug 2009 → …

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2011 2022

Research Output 2002 2019

Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia

Rees, V. E., Deveson Lucas, D. S., López-Causapé, C., Huang, Y., Kotsimbos, T., Bulitta, J. B., Rees, M. C., Barugahare, A., Peleg, A. Y., Nation, R. L., Oliver, A., Boyce, J. D. & Landersdorfer, C. B., 1 Apr 2019, In : Antimicrobial Agents and Chemotherapy. 63, 4, 11 p., e02538-18.

Research output: Contribution to journalArticleResearchpeer-review

Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic Fibrosis

Bulitta, J. B., Jiao, Y., Drescher, S. K., Oliver, A., Louie, A., Moya, B., Tao, X., Wittau, M., Tsuji, B. T., Zavascki, A. P., Shin, B. S., Drusano, G. L., Sörgel, F. & Landersdorfer, C. B., 6 Feb 2019, In : Clinical Pharmacokinetics. 58, 2, p. 143-156 14 p.

Research output: Contribution to journalArticleResearchpeer-review

Optimization of dosing regimens of intravenous colistin in patients with cystic fibrosis: What data are required?

Nation, R. L. & Landersdorfer, C. B., 2019, In : Pediatric Pulmonology. 54, 10, p. 1497-1498 3 p.

Research output: Contribution to journalLetterOtherpeer-review

Combating Carbapenem-Resistant Acinetobacter baumannii by an Optimized Imipenem-plus-Tobramycin Dosage Regimen: Prospective Validation via Hollow-Fiber Infection and Mathematical Modeling

Landersdorfer, C. B., Yadav, R., Rogers, K. E., Kim, T. H., Shin, B. S., Boyce, J. D., Nation, R. L. & Bulitta, J. B., 1 Apr 2018, In : Antimicrobial Agents and Chemotherapy. 62, 4, 8 p., e02053-17.

Research output: Contribution to journalArticleResearchpeer-review

Differences in suppression of regrowth and resistance despite similar initial bacterial killing for meropenem and piperacillin/tazobactam against Pseudomonas aeruginosa and Escherichia coli

Bergen, P. J., Bulitta, J. B., Sime, F. B., Lipman, J., McGregor, M. J., Millen, N., Paterson, D. L., Kirkpatrick, C. M. J., Roberts, J. A. & Landersdorfer, C. B., 1 May 2018, In : Diagnostic Microbiology and Infectious Disease. 91, 1, p. 69-76 8 p.

Research output: Contribution to journalArticleResearchpeer-review


ASCEPT Denis Wade J&J New Investigator Award

Cornelia Landersdorfer (Recipient), 2013

Prize: Prize (including medals and awards)

Georgina Sweet Award for Women in Quantitative Biomedical Science

Cornelia Landersdorfer (Recipient), 8 Oct 2018

Prize: Prize (including medals and awards)

Activities 2013 2020

30th European Congress of Clinical Microbiology & Infectious Diseases

Cornelia Landersdorfer (Invited speaker)
Apr 2020 → …

Activity: Participating in or organising an event typesContribution to conference

Co-chair ASCEPT Drug Disposition and Response Special Interest Group

Cornelia Landersdorfer (Chair/ Co-Chair)
Nov 2019 → …

Activity: External Academic EngagementProfessional association or peak discipline body

ASCEPT-PAGANZ conference

Cornelia Landersdorfer (Session chair)
25 Nov 2019

Activity: Participating in or organising an event typesContribution to conference

Antimicrobial Agents and Chemotherapy (Journal)

Cornelia Landersdorfer (Editorial board member)
1 Jan 201931 Dec 2021

Activity: Publication peer-review and editorial work typesEditorial responsibility

ARC Discovery Project Detailed Assessor

Cornelia Landersdorfer (Reviewer)
2018 → …

Activity: External Academic EngagementGrant review responsibilities

Press / Media

Interview for documentary on superbugs - a different lens

Cornelia Landersdorfer


1 item of Media coverage

Press/Media: Profile/Interview

Radio interview on superbugs research

Cornelia Landersdorfer


1 item of Media coverage

Press/Media: Profile/Interview